The opening by the United States and the European Union to a possible suspension of patents on Covid vaccines “is an important step in so far as it indicates that the need to address the problem in a global way and the need for it is well recognized. there are vaccines for everyone, with a view to equity and interest of the whole world including the areas most in difficulty. But this is not the decisive element, rather it is more of an image “. So Fabrizio Pregliasco comments on the news at Adnkronos Salute. Read also The point, underlines the virologist of the State University of Milan, is that it is not just a matter of patents. “It is a question of having the industrial aspect, the biorectors. It is not that vaccines are made in a subscale – he specifies – We need technology, we need a series of quality controls, active ingredients, raw materials”. And then, Pregliasco warns, “let’s not take everything away from Big Pharma. It is difficult to talk about Big Pharma – he observes – because there is a polarization: one is either for or against. But surely an evaluation of common sense compared to the fact that there must be an acknowledgment of the industrial risk aspect, because if we take this away from it, which other private companies will want to throw themselves into research in the future? “.” There was still a considerable investment – he remembers – Even if it is true that in many cases there have been investments with public contributions, however – concludes Pregliasco – let’s try to find a mitigation to ensure that there are not those negative effects of what is the war economy “.